Bob Spirko is well known in the Calgary, Alberta, area, for his website, http://bobspirko.ca, that provides reliable information on many of the mountain scrambles in the local Rocky Mountains. This kind of scrambling has nothing to do with the scrambled sensations of schizophrenia except that, many years ago, Bob suffered from this condition. For reasons he can’t quite explain he decided …
The Personal Computer Radio Show – 11.22.17
Personal Computer Show Wednesday, November 22nd 2017 Broadcast prn.live on the INTERNET 6:00 PM ET IN THE NEWS Microsoft Will End Free Windows 10 Upgrade December 31: Work Around with Windows 10 ISO file How to remove software leftover artifacts: IObit Uninstaller 7 Free and Advanced SystemCare Free. Google Docs went down for ‘a significant’ number of users for over …
Heather Callaghan – Are Supplement Hit Pieces A Natural Health False Flag?
Like a script from a movie you already know the ending to; each year we can expect a hoax study or attack on anything that is not FDA approved. It is with great hope that the average person will have enough sense to see through the latest propaganda of “debunking” all supplements based on faulty, cheap ones and those investigated …
The Dr. Peter Breggin Hour – 11.11.15
Nightmarish social control becomes a medical reality. My guest Michael Cornwall blows the whistle on probable FDA approval of a lobotomizing antipsychotic drug with a microchip that tells authorities whether you have really swallowed it. The brutal personal and societal implications are staggering.
Expanding Mind – Documenting Divinorum – 09.24.15
A talk with anthropologists and filmmakers Roberto Lopez Melinchon and Nicholas Spiers about the indigenous use of salvia divinorum, the plant’s healing powers, and current attempts to ban salvia in Mexico. http://divinorum-doc.com
Martha Rosenberg – Big Pharma’s Profiteers: You Want Us to Pay What for These Meds?
It is no secret that the pill profit party is over for drug companies. Bestselling pills like Lipitor, Seroquel, Zyprexa, Singular, Concerta, Cymbalta and Abilify have gone off patent and Wall Street is moving on to industries that offer better returns. To combat investor disenchantment, drug companies have rolled out expensive drugs that treat such rare conditions, they almost sound …